These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19732493)

  • 1. Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice.
    Kawase A; Matsumoto Y; Hadano M; Ishii Y; Iwaki M
    J Pharm Pharm Sci; 2009; 12(2):150-63. PubMed ID: 19732493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2.
    Wang X; Morris ME
    Drug Metab Dispos; 2007 Feb; 35(2):268-74. PubMed ID: 17093006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.
    Adkison KK; Vaidya SS; Lee DY; Koo SH; Li L; Mehta AA; Gross AS; Polli JW; Lou Y; Lee EJ
    Br J Clin Pharmacol; 2008 Aug; 66(2):233-9. PubMed ID: 18429968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice.
    Zhang S; Wang X; Sagawa K; Morris ME
    Drug Metab Dispos; 2005 Mar; 33(3):341-8. PubMed ID: 15608138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in rats.
    Huang L; Be X; Tchaparian EH; Colletti AE; Roberts J; Langley M; Ling Y; Wong BK; Jin L
    J Pharmacol Exp Ther; 2012 Nov; 343(2):316-24. PubMed ID: 22869929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
    Zhang Y; Wang H; Unadkat JD; Mao Q
    Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pregnancy on nitrofurantoin disposition in mice.
    Zhang Y; Zhou L; Unadkat JD; Mao Q
    J Pharm Sci; 2009 Nov; 98(11):4306-15. PubMed ID: 19422048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
    Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
    Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.
    Zaher H; Khan AA; Palandra J; Brayman TG; Yu L; Ware JA
    Mol Pharm; 2006; 3(1):55-61. PubMed ID: 16686369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the oral drug absorption of topotecan through the inhibition of intestinal xenobiotic efflux transporter, breast cancer resistance protein, by excipients.
    Yamagata T; Kusuhara H; Morishita M; Takayama K; Benameur H; Sugiyama Y
    Drug Metab Dispos; 2007 Jul; 35(7):1142-8. PubMed ID: 17446265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
    Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
    Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
    Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice.
    Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00544. PubMed ID: 31988753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved In vivo Effect of Chrysin as an Absorption Enhancer Via the Preparation of Ternary Solid Dispersion with Brij®L4 and Aminoclay.
    Lee SH; Lee YS; Song JG; Han HK
    Curr Drug Deliv; 2019; 16(1):86-92. PubMed ID: 30246640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and breast cancer resistance protein affect disposition of tandutinib, a tyrosine kinase inhibitor.
    Yang JJ; Milton MN; Yu S; Liao M; Liu N; Wu JT; Gan L; Balani SK; Lee FW; Prakash S; Xia CQ
    Drug Metab Lett; 2010 Dec; 4(4):201-12. PubMed ID: 20670210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
    Pingili RB; Pawar AK; Challa SR
    Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
    Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
    J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport.
    Zhang S; Yang X; Morris ME
    Pharm Res; 2004 Jul; 21(7):1263-73. PubMed ID: 15290869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.